An economic analysis of hand transplantation in the United States

Plastic and Reconstructive Surgery

Volumn 125, Issue 2, 2010, Pages 589-598

  Chung, Kevin C ^a,b,c   Oda, Takashi ^a,b,c   Saddawi Konefka, Daniel ^a,b,c   Shauver, Melissa J ^a,b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c ST JOSEPH MERCY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; COST BENEFIT ANALYSIS; DRUG COST; ECONOMICS; FEMALE; FOREARM; GRAFT REJECTION; HAND; HOSPITAL COST; HUMAN; INFORMATION PROCESSING; LIMB PROSTHESIS; MALE; MEDICARE; MORTALITY; ORGAN TRANSPLANTATION; OUTPATIENT DEPARTMENT; POSTOPERATIVE COMPLICATION; QUALITY ADJUSTED LIFE YEAR; STATISTICS; TRANSPLANTATION; TRAUMATIC AMPUTATION; TREATMENT OUTCOME; UNITED STATES;

ADULT; AMBULATORY CARE FACILITIES; AMPUTATION, TRAUMATIC; ARTIFICIAL LIMBS; COST-BENEFIT ANALYSIS; DATA COLLECTION; DRUG COSTS; FEMALE; FOREARM; GRAFT REJECTION; HAND; HOSPITAL COSTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MEDICARE; ORGAN TRANSPLANTATION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES; YOUNG ADULT;

EID: 76949104045     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181c82eb6     Document Type: Article

References (60)

1. Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: Report on first 6 months. Lancet 1999;353:1315-1320. (Pubitemid 29178782)
2. Jones JW, Gruber SA, Barker JH, et al. Successful hand transplantation: One-year follow-up. Louisville Hand Transplant Team. N Engl J Med. 2000;343:468-473.
3. Francois CG, Breidenbach WC, Maldonado C, et al. Hand transplantation: Comparisons and observations of the first four clinical cases. Microsurgery 2000;20:360-371.
4. Dubernard JM, Petruzzo P, Lanzetta M, et al. Functional results of the first human double-hand transplantation. Ann Surg. 2003;238:128-136.
5. Lanzetta M, Nolli R, Borgonovo A, et al. Hand transplantation: Ethics, immunosuppression and indications. J Hand Surg (Br.) 2001;26:511-516.
6. Margreiter R, Brandacher G, Ninkovic M, et al. A doublehand transplant can be worth the effort! Transplantation 2002;74:85-90.
7. Lanzetta M, Petruzzo P, Margreiter R, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 2005;79:1210-1214.
8. Lanzetta M, Petruzzo P, Dubernard JM, et al. Second report (1998-2006) of the International Registry of Hand and Composite Tissue Transplantation. Transpl Immunol. 2007;18:1-6.
9. Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue transplantation. Transplantation 2008;86:487-492.
10. Breidenbach WC, Gonzales NR, Kaufman CL, et al. Outcomes of the first 2 American hand transplants at 8 and 6 years posttransplant. J Hand Surg (Am.) 2008;33:1039-1047.
11. Ravindra KV, Buell JF, Kaufman CL, et al. Hand transplantation in the United States: Experience with 3 patients. Surgery 2008;144:638-643; discussion 643-644.
12. Lee WP. Composite tissue transplantation: More science and patience needed. Plast Reconstr Surg. 2001;107:1066-1070.
13. Brenner MJ, Tung TH, Jensen JN, et al. The spectrum of complications of immunosuppression: Is the time right for hand transplantation? J Bone Joint Surg (Am.) 2002;84:1861-1870.
14. Baumeister S, Kleist C, Dohler B, et al. Risks of allogeneic hand transplantation. Microsurgery 2004;24:98-103.
15. Foucher G. Prospects for hand transplantation. Lancet 1999; 353:1286-1287.
16. Herndon JH. Composite-tissue transplantation: A new frontier. N Engl J Med. 2000;343:503-505.
17. Cendales L, Hardy MA. Immunologic considerations in composite tissue transplantation: Overview. Microsurgery 2000;20: 412-419.
18. Hettiaratchy S, Randolph MA, Petit F, et al. Composite tissue allotransplantation: A new era in plastic surgery? Br J Plast Surg. 2004;57:381-391.
19. Swearingen B, Ravindra K, Xu H, et al. Science of composite tissue allotransplantation. Transplantation 2008;86:627-635.
20. Manske PR. Hand transplantation. J Hand Surg (Am.) 2001; 26:193-195.
21. Gaine WJ, Smart C, Bransby-Zachary M. Upper limb traumatic amputees: Review of prosthetic use. J Hand Surg (Br.) 1997;22:73-76.
22. Biddiss EA, Chau TT. Upper limb prosthesis use and abandonment: A survey of the last 25 years. Prosthet Orthot Int. 2007;31:236-257.
23. Biddiss E, Chau T. Upper-limb prosthetics: Critical factors in device abandonment. Am J Phys Med Rehabil. 2007;86:977-987.
24. Chung KC, Walters MR, Greenfield ML, et al. Endoscopic versus open carpal tunnel release: A cost-effectiveness analysis. Plast Reconstr Surg. 1998;102:1089-1099.
25. Brauer CA, Rosen AB, Olchanski NV, et al. Cost-utility analyses in orthopaedic surgery. J Bone Joint Surg (Am.) 2005;87: 1253-1259.
26. Myers J, McCabe S, Gohmann S. Economic analysis in hand surgery. J Hand Surg (Am.) 2006;31:664-668.
27. Davis EN, Chung KC, Kotsis SV, et al. A cost/utility analysis of open reduction and internal fixation versus cast immobilization for acute nondisplaced mid-waist scaphoid fractures. Plast Reconstr Surg. 2006;117:1223-1235; discussion 1236-1238.
28. Cugno S, Sprague S, Duke A, et al. Composite tissue allotransplantation of the face: Decision analysis model. Can J Plast Surg. 2005;15:145-152.
29. Weinstein MC, Fineberg HV. Probabilities and clinical decisions. In Weinstein MC, Fineberg HV, eds. Clinical Decision Analysis. Philadelphia: W. B. Saunders; 1980.
30. Thoma A, Sprague S, Tandan V. Users' guide to the surgical literature: How to use an article on economic analysis. Can J Surg. 2001;44:347-354. (Pubitemid 32954704)
31. Arias E. United States Life Tables, 2003. Natl Vital Stat Rep. 2006;54:1-40.
32. Current Procedural Terminology. Chicago: American Medical Association; 2009.
33. Medicare RBRVS. Chicago: American Medical Association; 2009.
34. Hariharan S. Recommendations for outpatient monitoring of kidney transplant recipients. Am J Kidney Dis. 2006;47: S22-S36.
35. Medical Learning Network. Acute Inpatient Prospective Payment System. Baltimore, Md.: Centers for Medicare and Medicaid Services; September 2009. Available at: www.cms.hhs.gov/ MLNProducts/Downloads/AcutePaymtSysfctsht.pdf. Accessed June 8, 2009.
36. Hospital Outpatient Prospective Payment System (OPPS). Baltimore, Md.: Centers for Medicare and Medicaid Services; 2009. Available at: http://www.cms.hhs.gov/LimitedDataSets/ 06-HospitalOPPS.asp. Accessed June 10, 2009.
37. Red Book. Montvale, N.J.: Thomson Healthcare; 2008.
38. Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant. 2003;3:590-598.
39. Petitti DB. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine. 2nd ed. New York: Oxford University Press; 2000:196-199.
40. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996;276:1253-1258.
41. Lidgren L. The bone and joint decade 2000-2010. Bull World Health Organ. 2003;81:629.
42. May 2008 National Occupational Employment and Wage Estimates United States, Occupational Employment Statistics. Washington, D.C.: Bureau of Labor and Statistics, United States Department of Labor; 2008.
43. Newby LK, Eisenstein EL, Califf RM, et al. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med. 2000;342:749-755.
44. Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 2000;283:889-896.
45. Braithwaite RS, Meltzer DO, King JT Jr, et al What does the value of modern medicine say about the $50,000 per qualityadjusted life-year decision rule? Med Care 2008;46:349-356.
46. Novak EJ, Silverstein MD, Bozic KJ. The cost-effectiveness of computer-assisted navigation in total knee arthroplasty. J Bone Joint Surg (Am.) 2007;89:2389-2397.
47. Larsen K, Hansen TB, Thomsen PB, et al. Cost-effectiveness of accelerated perioperative care and rehabilitation after total hip and knee arthroplasty. J Bone Joint Surg (Am.) 2009; 91:761-772.
48. Lee CP, Chertow GM, Zenios SA. An empiric estimate of the value of life: Updating the renal dialysis cost-effectiveness standard. Value in Health 2009;12:80-87.
49. Garner TI, Dardis R. Cost-effectiveness analysis of end-stage renal disease treatments. Med Care 1987;25:25-34.
50. Simmons RG, Abress L, Anderson CR. Quality of life after kidney transplantation: A prospective, randomized comparison of cyclosporine and conventional immunosuppressive therapy. Transplantation 1988;45:415-421.
51. Krueger H. Economic analysis of solid organ transplantation: A review for policy makers. Health Policy 1989;13:1-17.
52. Chen NC, Shauver MJ, Chung KC. A primer on use of decision analysis methodology in hand surgery. J Hand Surg (Am.) 2009;34:983-990.
53. McCabe S, Rodocker G, Julliard K, et al. Using decision analysis to aid in the introduction of upper extremity transplantation. Transplant Proc. 1998;30:2783-2786.
54. Manske PR. The sound of one hand clapping. J Hand Surg (Am.) 2008;33:1037-1038.
55. Kahan BD, Ghobrial R. Immunosuppressive agents. Surg Clin North Am. 1994;74:1029-1054.
56. Graham B, Adkins P, Tsai TM, et al. Major replantation versus revision amputation and prosthetic fitting in the upper extremity: A late functional outcomes study. J Hand Surg (Am.) 1998;23:783-791.
57. Edgell SE, McCabe SJ, Breidenbach WC, et al. Different reference frames can lead to different hand transplantation decisions by patients and physicians. J Hand Surg (Am.) 2001; 26:196-200.
58. Russell LB, Gold MR, Siegel JE, et al. The role of costeffectiveness analysis in health and medicine: Panel on Cost- Effectiveness in Health and Medicine. JAMA. 1996;276:1172-1177.
59. Majzoub RK, Cunningham M, Grossi F, et al. Investigation of risk acceptance in hand transplantation. J Hand Surg (Am.) 2006;31:295-302. (Pubitemid 43227283)
60. Ravindra KV, Wu S, Bozulic L, et al. Composite tissue transplantation: A rapidly advancing field. Transplant Proc. 2008; 40:1237-1248.